TABLE 2.
Infections | Urticaria | Inflammatory disorders | Drug eruption | Ulcers | Benign tumor | Malignant tumor | Total | |
---|---|---|---|---|---|---|---|---|
Emergency | ||||||||
Female | 4 (66.7%) | 1 (16.7%) | 1 (16.7%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 6 (100%) |
Male | 2 (66.7%) | 1 (33.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) |
Total | 6 (66.7%) | 2 (22.2%) | 1 (11.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 9 (100%) |
Internal medicine | ||||||||
Female | 6 (30%) | 1 (5%) | 8 (40%) | 2 (10%) | 2 (10%) | 0 (0%) | 1 (5%) | 20 (100%) |
Male | 7 (26.9%) | 1 (3.8%) | 9 (34.6%) | 4 (15.4%) | 3 (11.5%) | 1 (3.8%) | 1 (3.8%) | 26 (100%) |
Total | 13 (28.3%) | 2 (4.3%) | 17 (37%) | 6 (13%) | 5 (10.9%) | 1 (2.2%) | 2 (4.3%) | 46 (100%) |
Intensive care | ||||||||
Female | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) | 0 (0%) | 0 (0%) | 2 (100%) |
Male | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) |
Total | 2 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (50%) | 0 (0%) | 0 (0%) | 4 (100%) |
Pediatrics | ||||||||
Female | 3 (60%) | 0 (0%) | 1820%) | 0 (0%) | 1 (20%) | 0 (0%) | 0 (0%) | 5 (100%) |
Male | 2 (40%) | 0 (0%) | 3 (60%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (100%) |
Total | 5 (50%) | 0 (0%) | 4 (40%) | 0 (0%) | 1 (10%) | 0 (0%) | 0 (0%) | 10 (100%) |
Pediatric ICU | ||||||||
Female | 1 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) |
Male | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Total | 1 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) |
Infectious disease | ||||||||
Female | 1 (50%) | 0 (0%) | 1 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) |
Male | 3 (60%) | 0 (0%) | 1 (20%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (20%) | 5 (100%) |
Total | 4 (57.1%) | 0 (0%) | 2 (28.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (14.3%) | 7 (100%) |
Physical medicine and rehabilitation | ||||||||
Female | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (100%) |
Male | 0 (0%) | 0 (0%) | 0 (0%) | 1 (33.3%) | 1 (33.3%) | 0 (0%) | 1 (33.3%) | 3 (100%) |
Total | 0 (0%) | 0 (0%) | 0 (0%) | 1 (33.3%) | 1 (33.3%) | 0 (0%) | 1 (33.3%) | 3 (100%) |
Cardiology | ||||||||
Female | 1 (50%) | 0 (0%) | 1 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) |
Male | 0 (0%) | 0 (0%) | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) |
Total | 1 (25%) | 0 (0%) | 3 (75%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (100%) |
Neurology | ||||||||
Female | 1 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) |
Male | 2 (66.7%) | 0 (0%) | 1 (33.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) |
Total | 3 (75%) | 0 (0%) | 1 (25%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (100%) |
COVID ward | ||||||||
Female | 4 (22.2%) | 4 (22.2%) | 9 (50%) | 1 (5.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 18 (100%) |
Male | 11 (47.8%) | 5 (21.7%) | 4 (17.4%) | 2 (8.7%) | 1 (4.3%) | 0 (0%) | 0 (0%) | 23 (100%) |
Total | 15 (36.6%) | 9 (22%) | 13 (31.7%) | 3 (7.3%) | 1 (2.4%) | 0 (0%) | 0 (0%) | 41 (100%) |
COVID ICU | ||||||||
Female | 2 (40%) | 0 (0%) | 3 (60%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (100%) |
Male | 4 (50%) | 1 (12.5%) | 2 (25%) | 0 (0%) | 1 (12.5%) | 0 (0%) | 0 (0%) | 8 (100%) |
Total | 6 (46.2%) | 1 (7.7%) | 5 (38.5%) | 0 (0%) | 1 (7.7%) | 0 (0%) | 0 (0%) | 13 (100%) |
Surgery | ||||||||
Female | 1 (11.1%) | 1 (11.1%) | 3 (33.3%) | 2 (22.2%) | 1 (11.1%) | 0 (0%) | 1 (11.1%) | 9 (100%) |
Male | 4 (30.8%) | 3 (23.1%) | 3 (23.1%) | 1 (7.7%) | 2 (15.4%) | 0 (0%) | 0 (0%) | 13 (100%) |
Total | 5 (22.7%) | 4 (18.2%) | 6 (27.3%) | 3 (13.6%) | 3 (13.6%) | 0 (0%) | 1 (4.5%) | 22 (100%) |
Psychiatry | ||||||||
Female | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) | 0 (0%) | 1 (100%) |
Male | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) |
Total | 0 (0%) | 0 (0%) | 1 (50%) | 0 (0%) | 1 (100%) | 0 (0%) | 0 (0%) | 2 (100%) |